A microbiota-derived antigen drives CD4⁺ intraepithelial lymphocyte (CD4IEL) development

Area of Science:

• Immunology
• Microbiome Research
• Gastroenterology

Background:

• CD4+ intraepithelial lymphocytes (CD4IEL) are crucial for maintaining intestinal homeostasis.
• These T cells possess both cytotoxic and regulatory functions.
• Peripheral regulatory T cells also play a key role in controlling gut inflammation.

Purpose of the Study:

• To identify microbial factors that influence CD4IEL differentiation and function.
• To explore the therapeutic potential of microbiota-derived antigens in inflammatory conditions.

Main Methods:

• Identification of a specific conserved antigen derived from gut microbiota.
• Assessment of the antigen's effect on CD4IEL differentiation in vitro.
• Evaluation of the antigen's impact on the severity of experimental colitis in mice.

Main Results:

• A microbiota-derived conserved antigen was identified.
• This antigen successfully induced CD4IEL differentiation.
• Administration of the antigen attenuated the severity of murine colitis, highlighting its regulatory function.

Conclusions:

• Microbiota-derived antigens can program CD4IELs towards a regulatory phenotype.
• Targeting these antigens presents a promising strategy for treating intestinal inflammation.
• This finding deepens our understanding of the gut-T cell axis in health and disease.